At EOT, c.35G>C KRAS was still detected in CTCFAPα, but a new c.35G>T (p.G12V) KRAS was now detected in both CTCFAPα and CTCEpCAM subpopulations, possibly indicating the evolution of a different clone of tumor cells ~120 days after treatment. Here, KRAS is linked to neoplasm.